SC 13G

Company

Lyra Therapeutics, Inc.

Filed

June 12, 2023

Accession Number

0001104659-23-070449

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →